Farallon Capital Management’s ImageneBio IMA Stock Holding History
Bought
Maintained
Sold
Other funds holding IMA
AG
Farallon Capital Management's IMA Position: Q3 2022 in Review
Farallon Capital Management sold out of ImageneBio (IMA) in Q3 2022, closing a stake of 24,167 shares — an estimated $1.28M sold.
Farallon Capital Management first reported a position in IMA in Q1 2021 and held it in 6 quarters. The position peaked at $38.1M in Q1 2021. 42 funds tracked by Wall St. Rank hold IMA as of Q3 2022.
- Farallon Capital Management reported no remaining ImageneBio position as of Q3 2022 after selling out during the quarter.
- Farallon Capital Management sold 24,167 ImageneBio shares in Q3 2022, an estimated $1.28M.
- Farallon Capital Management first reported a position in ImageneBio in Q1 2021 and held it in 6 quarters.
- Farallon Capital Management's ImageneBio position peaked at $38.1M in Q1 2021.
- 42 funds tracked by Wall St. Rank held ImageneBio as of Q3 2022.
Based on Farallon Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.